Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cv Sciences Inc (OP:CVSI)

0.0271 -0.0014 (-4.91%)
Streaming Delayed Price Updated: 3:57 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cv Sciences Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Bullish Sentiment Across The Cannabis Space - Check Full Movers For September 4, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Friday For Marijuana Stocks - AusCann Group Holdings, Affinor Growers Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
CV Sciences FY22 Revenue Declines 19% To $16.2M
CV Sciences, Inc. (OTCQB: CVSI) FY 2022 revenue was $16.2 million, a 19% decrease compared to $20.0 million for 2021. Q4 2022 Financial Highlights 
Via Benzinga
Bullish Thursday For Marijuana Stocks - Australis Capital, Choom Holdings Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For August 29, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From August 24, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For August 23, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Publicly Traded Hemp-Focused Wellness Company Reports Q2 Results, Here Is What You Need To Know
CV Sciences, Inc. (OTCQB: CVSI) reported Monday its financial results for the quarter ended June 30, 2023, disclosing revenue of $4.0 million, compared to $4.1 million for the same period of 2022. 
Via Benzinga
Cannabis Stock Gainers And Losers From August 16, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers
Via Benzinga
Marijuana Stock Movers For August 15, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 17, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Thursday For Marijuana Stocks - Choom Holdings, EVIO Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For July 12, 2023
Via Benzinga
Marijuana Stock Movers For August 8, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 11, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From August 4, 2023
Via Benzinga
Cannabis Stock Movers For July 10, 2023
Via Benzinga
Marijuana Stock Movers For August 2, 2023
Via Benzinga
CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know
CV Sciences, Inc. (OTCQB: CVSI) released its financial results today for the first quarter ended March 31, 2023, revealing revenues of $4.1 million for the first quarter of 2023 compared to $4.4... 
Via Benzinga
Popular CBD Brand Questions Study: 'Misleading To Consumers And Damaging To The Industry'
NextEvo Naturals recently released results from a third-party study on 16 CBD products that were allegedly randomly selected for the research. The brand commissioned Coral Reef Labs to conduct this... 
Via Benzinga
Marijuana Stock Movers For July 31, 2023
Via Benzinga
CBD And Nicotine Formula To Treat Smokeless Tobacco Addiction Receives Patent From Japan, FDA Approval Next
CV Sciences, Inc. (OTCQB: CVSI) received a formal certificate of grant from the Japan Patent Office for its patent application 7216697. 
Via Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From July 26, 2023
Via Benzinga
Cannabis Stock Movers For July 24, 2023
Via Benzinga
Cannabis Stock Movers For July 19, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.